Viking Therapeutics, Inc. (VKTX) /
The debt of Viking Therapeutics, Inc. over the past 10 years
Chart Viking Therapeutics, Inc.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Viking Therapeutics, Inc. had liquid cash of $705.74M and total debt of $0: net cash of $705.74M. It had more liquid cash than debt at all 10 year-ends shown. Total debt was highest at the end of fiscal 2017 ($4.85M) and lowest at the end of fiscal 2018 ($0).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $705.74M* | $0 | $705.74M |
| 2024ended Dec 31, 2024 | $902.61M* | $0 | $902.61M |
| 2023ended Dec 31, 2023 | $362.08M* | $0 | $362.08M |
| 2022ended Dec 31, 2022 | $155.49M* | $0 | $155.49M |
| 2021ended Dec 31, 2021 | $202.1M* | $0 | $202.1M |
| 2020ended Dec 31, 2020 | $248.39M* | $0 | $248.39M |
| 2019ended Dec 31, 2019 | $275.64M* | $0 | $275.64M |
| 2018ended Dec 31, 2018 | $301.52M* | $0 | $301.52M |
| 2017ended Dec 31, 2017 | $20.57M* | $4.85M | $15.73M |
| 2016ended Dec 31, 2016 | $13.15M* | $4M | $9.15M |
Fiscal years as Viking Therapeutics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Viking Therapeutics, Inc.
- The revenue of Viking Therapeutics, Inc.
- The profitability of Viking Therapeutics, Inc.
- All of Viking Therapeutics, Inc.'s financials, charted
Companies of a similar size
- DRHDIAMONDROCK HOSPITALITY CO
- GLXYGalaxy Digital Inc.
- ARCBARCBEST CORPORATION
- KNKnowles Corporation
- COTYCOTY INC.
Not investment advice. This page shows what Viking Therapeutics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.